Based on the Teladoc Inc stock forecasts from 26 analysts, the average analyst TDOC stock price target is USD 76.19 over the next 12 months. Teladoc Inc’s average analyst rating is Buy. Stock Target Advisor’s own TDOC stock forecast is Slightly Bullish, which is based on 6 positive signals and 4 negative signals. At the last closing, Teladoc stock price was USD 43.24. Teladoc stock price has changed by +0.04% over the past week, +5.78% over the past month and -71.52% over the last year.
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
What we like:
High market capitalization:
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior risk adjusted returns:
The Teladoc stock price has performed well, on a risk adjusted basis, compared to its sector peers (for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value:
The Teladoc stock price is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The company is less leveraged than its peers, and is among the top quartile, which makes it more flexible. However, do check the TDOC stock forecast and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow:
The company had positive total cash flow in the most recent four quarters.
Superior Revenue Growth:
The Teladoc stock price has shown top quartile revenue growth in the previous 5 years compared to its sector.
What we don’t like:
The total returns for Teladoc stock price are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis:
The Teladoc stock price is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow:
The Teladoc stock price had negative total free cash flow in the most recent four quarters.
Low Earnings Growth:
The Teladoc stock price has shown below median earnings growth in the previous 5 years compared to its sector.